The human induced pluripotent stem cell (hiPSC) line, derived from dermal ibroblasts from Leber congenital amaurosis patient with homozygous mutation c.265 T > C, p.Cys89Arg in aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) was generated by Sendai virus reprogramming. The generated hiPSC line was free of Sendai virus genes, had stable karyotype, carried the homozygous mutation, was immunopositive to pluripotency markers and able to generate all three germ layers upon embryoid body formation.
Resource utility
Human induced pluripotent stem cells (hiPSCs) hold great potential in regenerative medicine as they can be expanded indeinitely and coaxed toward any cell type of the human body including photoreceptors (Zhong et al., 2014 ) the afected cells in patients with blinding diseases. Leber congenital amaurosis (LCA) is the severest form of inherited retinal dystrophies characterized by loss of electroretinogram signal and severe visual impairment within the irst year of life (Kumaran et al., 2017) . We describe here the generation of the hiPSC line from LCA patient with homozygous mutation c.265 T > C, p.Cys89Arg in aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1), a photoreceptor speciic chaperone (Ramamurthy et al., 2004) . This iPSC line presents a renewable and patient speciic cell source which holds the potential for in vitro disease modelling in which to perform therapeutic screening and also as a cell source for autologous replacement therapy after mutation correction.
Resource details
The ibroblasts were derived from skin biopsy from a female patient diagnosed with Leber congenital amaurosis, expanded and reprogramed using Sendai virus (CytoTune™). Individual colonies were picked and subcultured into individual cell lines and analyzed at cellular and genetic level to conirm successful reprogramming (Table 1) . The generated hiPSC line LCA-FiPS4F1 carried the mutation in aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) (Fig. 1A) in accordance with previous genotyping results in the patient. After 30 days generated colonies displayed a typical human embryonic stem cell (hESC) colony-like morphology with refractive edges as seen by phase contrast (PC) microscopy ( Fig. 1B) and the cells had high nuclear/cytoplasmic ratio. All colonies in the plastic dish were positive for alkaline phosphatase (Fig. 1C, left) and coloured colonies were detected microscopically (Fig. 1C, right) . Pluripotency was assessed by low cytometry for SSEA-4 and TRA-1-60 pluripotency markers (Fig. 1D ) and immunocytochemistry to pluripotency markers OCT4, SOX2, NANOG, SSEA-4 and TRA-1-81 (Fig. 1E) . The expression of endogenous pluripotency genes was detected by RT-PCR (Fig. 1F) . To test the ability of the hiPSC line to generate derivatives of three germ layers in vitro, the embryoid body (EB) based assay was performed. Spontaneously differentiated cells were immunostained for endodermal markers forkhead box A2 (FOXA2, inset showing simultaneous DAPI staining) and α-fetoprotein (AFP), ectodermal markers β-III tubulin (TUJ1)) and PAX6, mesodermal markers vimentin and α-smooth muscle actin (SMA) (Fig. 1G ). The genetic ingerprinting was performed and proved its genetic identity to parental ibroblasts (available with authors). The hiPSC line was karyotypically normal (Fig. 1H ). The presence of mycoplasma was regularly tested and was negative (Supplementary ile). The Sendai virus and exogenous reprogramming factors were cleared after 8 cell line passages (Fig. 1I ).
Materials and methods

Reprogramming fibroblasts
The primary ibroblasts derived from the skin biopsy were expanded for four passages in DMEM (10% FBS, 2 mM Glutamax, PenicillinStreptomycin 1×) at 37°C under 5% CO 2 , before being reprogrammed by a Sendai virus containing four genes: Oct3/4, Sox2, Klf4 and cMyc (CytoTune™, Thermo Fisher) according to manufacturer instructions. hiPSCs were grown on irradiated (45Gy) human foreskin ibroblasts (ATCC CRL 2429) in hiPSCs medium containing Knock-out DMEM, KSR 20%, Glutamax 2 mM, non-essential amino acids 0.1 mM, β-mercaptoethanol 0.23 mM, basic FGF 10 ng/ml, penicillin/streptomycin, at 37°C/5% CO 2 . The hiPSCs were adapted to feeder-free cell culture on Matrigel (BD, #354277) coated plates using mTeSR1 medium. Matrigel was diluted in DMEM/F-12 according to the dilution factor speciied on the certiicate of analysis and incubated for 1 h/RT at 1 ml/well of a 6- Stem Cell Research 33 (2018) 151-155 152 (caption on next page) D. Lukovic et al. Stem Cell Research 33 (2018) 151-155 well plate. Passages were performed using Dispase (STEMCELL Technologies, #07913), every 5-7 days at 1:6-1:10 split ratio.
In vitro differentiation assay
In vitro diferentiation was performed by EB formation, namely the iPSC colonies were lifted manually and cultured in non-adherent conditions in mTeSR1 medium for 24 h, followed by endoderm medium (Knockout-DMEM, 10% FBS, 1% Glutamax, NEAA 1%, β-mercaptoethanol 0,23 mM, Penicillin-Streptomycin 1×) for the following 6 days. Thereafter, the EBs were seeded on glass coverslips treated with 0,1% gelatin for 2 h/RT and cultured during 2 weeks in three cell culture media: ectoderm medium (50% Neurobasal medium, 50% DMEM/ F12, 1% N2 supplement, 0,5% B27 supplement, penicillin-streptomycin OCT3/4 CCCGAAAGAGAAAGCGAACCAG AATGTATCGAAGGTGCTCAA* 1×), endoderm medium and mesoderm medium (endoderm medium, 0,5 mM ascorbic acid). The coverslips were ixed 4% PFA for 15 min and analyzed by immunoluorescence (Table 2) . Confocal images were taken by Leica SP8.
Karyotype analysis
The karyotype was analyzed by G-banding at 400-550 band resolution, 30 metaphases analyzed (Service of Biobanco de Sistema Sanitario Público, Granada, Spain).
Fingerprinting
Genomic DNA from ibroblasts and hiPSCs was extracted using QIAamp DNA Blood mini kit (Qiagen) in the presence of RNAse (Roche). Fingerprinting analyses was performed using Promega kit 10 microsatellite markers (TH01, TPOX, vWA, CSF1PO, D16S539, D7S820, D13S317, D5S818 y D21S11, Amelogenin) and analyzed on Abi PRISM 3130 using GeneMapper (Thermo Fisher) by Biobanco de Sistema Sanitario Público, Granada, Spain.
Detection of pluripotency markers and vector elimination by RT-PCR
Total RNA was isolated with the RNeasy Mini Kit (Qiagen, Hilden, Germany), and treated with DNase I to remove any genomic DNA contamination. QuantiTect Reverse Transcription Kit (Qiagen) was used to carry out cDNA synthesis from 1 μg of total RNA according to the manufacturer's instructions. The expression level of pluripotency markers was analyzed using the primers described in Table 2 . Patient's ibroblasts (DF) were used as negative control while hESC H9 (WiCell) was used as positive control. For Sendai virus elimination test patient's ibroblasts were collected at day 7 after transduction as positive control (C+). The PCR reaction was performed with MyTaq DNA Polymerase (Bioline GmbH, Luckenwalde, Germany) using Applied Biosystems Veriti Thermal Cycler with following steps: denaturation 94°C; 15 s, annealing 50-65°C; 30 s, extension 72°C; 45 s, for 35 cycles. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression was used as a control housekeeping gene. Thereafter, PCR products were analyzed on 2% agarose gels.
Immunocytochemistry hiPSC colonies cultured in plastic dishes were washed in PBS and ixed in 4% PFA for 15 min at room temperature (RT). Fixed cells were washed twice in PBS and placed in blocking solution (3% serum, 0.5% Triton-X100 in PBS) for 1 h at RT. Cells were then incubated overnight at 4°C with primary antibodies (Table 2) . The following day, cells were washed three times in PBS and incubated with an appropriate secondary antibody at RT for 1 h. Thereafter, cells were stained with DAPI (1:1000) at RT during 5 min, washed three times in PBS and imaged at Leica DMi 8 microscope coupled with DFC/7000GT camera.
Flow cytometry
hiPSCs were dissociated using Accutase (Innovative Cell Technologies) for 2-4 min at RT, centrifuged at 300 rcf for 5 min and 100.000 cells resuspended in 200 μl PBS + 2% FBS. Anti-human SSEA-4, and anti-human TRA-1-60, both PE conjugated, antibodies were added and incubated for 20 min at RT. Isotype negative controls were used at the same inal concentration. The cells were analyzed using a CytoFLEX low cytometer (Beckman Coulter) and data analyzed by CytExpert 2.0 software.
Alkaline phosphatase Staining
Alkaline phosphatase staining was carried out using Alkaline Phosphatase Staining Kit II (Stemgent, MA).
Mycoplasma detection
The presence of mycoplasma was tested regularly measuring enzyme activity via luciferase (MycoAlert™ PLUS Mycoplasma Detection Kit, Lonza).
hiPSC nomenclature
The generated hiPSC line was named following Spanish National Stem Cell Bank recommendations. The line is registered at https:// hpscreg.eu/ as CIPFi001-A line.
